Skip to content
Gamora Technologies

The Zimbabwean Government Declines ‘Lopsided’ US Healthcare Assistance Deal Due to Data Apprehensions

Medical aid image
The proposed American financial assistance would have supported programmes for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has turned down a significant US health deal valued at 367 million US dollars (272 million pounds) over five years due to the United States' insistence on sensitive data.

This rejection came to light following a internal memorandum dated December was disclosed, which showed Head of State Emmerson Mnangagwa believed the agreement was "skewed".

An official representative later stated that the US was demanding access to genetic material for research and profit but was not willing to guarantee the resulting advantages from any future treatments.

"We must now begin the challenging and unfortunate task of scaling back our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy noted the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has called for more talks to reach a agreement agreeable to all parties so the country's critical HIV treatment initiative can continue.

Broader Implications

This development follows a comparable case in neighbouring Kenya, where a court blocked a related health funding agreement following legal challenges were raised about the security of Kenyans' health data.

Since returning to the presidency recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).

USAID had managed aid for the American government, but Trump claimed its spending was "inefficient" and his administration was pursuing direct bilateral deals to enhance openness and accountability.

Based on statements, Sixteen African countries have so far agreed to similar agreements, constituting over $18.3bn of fresh investment.

Details of the Declined Deal

The funds for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"It is our view this cooperation would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million currently on HIV treatment through US-supported programmes," Tremont added.

However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".

"The proposal required Zimbabwe to share its genetic material and health information for a long time, without any corresponding assurance of access to any medical innovations – like new medicines or tests – that might be developed from that shared data," Mangwana explained.

"In essence, our country would supply the basic resources for medical research with no assurance that the resulting innovations would be available to our citizens if a new pandemic emerge."

National Interest and International Frameworks

He also noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining frameworks previously established via the international organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to deal with future global health emergencies.

"This framework is designed to ensure that when a country provides its samples, the benefits – including vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to develop them."

Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," he added.

"We are open to further discussions with our American counterparts on how subsequent co-operation might be arranged in a way that honours the independence and interests of both nations."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but suggested that talks must proceed since a large portion of the country's HIV programmes relied on external financing.

"Where specific concerns arise, including those relating to data governance or implementation frameworks, these can frequently be resolved through detailed discussion and mutually agreed protections," the group added.

The situation underscores the continuing challenges between receiving crucial international aid and protecting national sovereignty in an ever more data-driven world.

AG
The writer

Anthony Gonzalez

A tech strategist with over a decade of experience in digital transformation and cloud solutions for UK enterprises.

Gamora Technologies

Type to search articles.